Susquehanna International Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Susquehanna International Group’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,090	Closed	-$23K	–	13612
2024 Q1	$23K	Buy	+2,090	New	+$22.6K	﹤0.01%	11790
2023 Q2	–	Sell	-3,290	Closed	-$91.1K	–	13769
2023 Q1	$91.1K	Buy	3,290 +3,066	+1,369%	+$104K	﹤0.01%	11365
2022 Q4	$7.29K	Sell	224 -393	-64%	-$28.7K	﹤0.01%	11986
2022 Q3	$74K	Sell	617 -254	-29%	-$45.7K	﹤0.01%	11958
2022 Q2	$152K	Sell	871 -508	-37%	-$107K	﹤0.01%	11011
2022 Q1	$400K	Sell	1,379 -2,689	-66%	-$1.02M	﹤0.01%	9547
2021 Q4	$2.13M	Buy	4,068 +3,326	+448%	+$2.39M	﹤0.01%	5362
2021 Q3	$282K	Buy	742 +312	+73%	+$134K	﹤0.01%	10742
2021 Q2	$383K	Buy	+430	New	+$329K	﹤0.01%	10240

Susquehanna International Group's BIOR Position: Q1 2024 in Review

Susquehanna International Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2024, closing a stake of 5,085 shares — an estimated $55K sold.

Susquehanna International Group first reported a position in BIOR in Q1 2021 and held it in 11 quarters. The position peaked at $3.23M in Q4 2021. 27 funds tracked by Wall St. Rank hold BIOR as of Q1 2024.

Susquehanna International Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Susquehanna International Group sold 5,085 Biora Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $55K.
Susquehanna International Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Susquehanna International Group's Biora Therapeutics, Inc. Common Stock position peaked at $3.23M in Q4 2021.
27 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.